⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL293573 | 0.85 | — | — | |
| SCHEMBL294350 | 0.83 | KDM4E (0.65) | — | |
| SCHEMBL18921037 | 0.81 | KDM4E (0.70) | — | |
| SCHEMBL8810963 | 0.81 | KDM4E (0.70) | — | |
| SCHEMBL109297 | 0.81 | KDM4E (0.70) | — | |
| SCHEMBL9636111 | 0.81 | KDM4E (0.70) | — | |
| SCHEMBL10061726 | 0.77 | — | — | |
| SCHEMBL48475 | 0.77 | — | — | |
| SCHEMBL8107 | 0.76 | KDM4E (0.71) | — | |
| SCHEMBL12061816 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 137 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017096260-A1 | METHODS AND MATERIALS FOR PRODUCING 7-CARBON MONOMERS | INVISTA NORTH AMERICA S.A.R.L. (US) | 2017-06-08 | — | — | WO | claimed |
| EP-1078002-B1 | PEPTIDE ANTIANGIOGENIC DRUGS | ABBOTT LAB (US) | 2008-05-21 | — | — | EP | claimed |
| CN-1916020-A | Peptide antiangiogenic drugs | ABBOTT LAB (US) | 2007-02-21 | — | — | CN | claimed |
| US-20050124548-A1 | Peptide antiangiogenic drugs | HENKIN JACK (US) | 2005-06-09 | — | — | US | claimed |
| US-6777535-B1 | USEFUL FOR TREATING CONDITIONS WHICH ARISE OR ARE EXACERBATED BY ANGIOGENESIS | ABBOTT LABORATORIES | 2004-08-17 | — | — | US | claimed |
| US-6753408-B1 | DRUGS USED FOR THERAPY | ABBVIE INC. | 2004-06-22 | — | — | US | claimed |
| US-6716963-B1 | OLIGOPEPTIDES | ABBOTT LABORATORIES | 2004-04-06 | — | — | US | claimed |
| US-20040063701-A1 | Piperidine derivatives and anti-platelet agents containing the same | AJINOMOTO CO., INC (JP) | 2004-04-01 | — | — | US | claimed |
| EP-0976735-B1 | PROCESS FOR PRODUCING PIPERIDINECARBOXYLIC ACID AMIDES | AJINOMOTO KK (JP) | 2003-10-29 | — | — | EP | claimed |
| US-20020147195-A1 | Piperidine derivatives and anti-platelet agents containing the same | AJINOMOTO CO., INC. (JP) | 2002-10-10 | — | — | US | claimed |
| EP-0682015-B1 | Piperidine derivates and anti-platelet agents containing the same | AJINOMOTO KK (JP) | 2001-08-22 | — | — | EP | claimed |
| WO-2001038347-A2 | PEPTIDES HAVING ANTIANGIOGENIC ACTIVITY | ABBOTT LABORATORIES (US) | 2001-05-31 | — | — | WO | claimed |
| EP-1103544-A2 | Piperidine derivatives and antiplatelet agents containing the same | Ajinomoto Co., Inc. (JP) | 2001-05-30 | — | — | EP | claimed |
| US-6207834-B1 | REACTING 2-OXAZOLINE COMPOUND WITH A PIPERIDINE DERIVATIVE | AJINOMOTO CO., INC. (JP) | 2001-03-27 | — | — | US | claimed |
| EP-1078002-A1 | PEPTIDE ANTIANGIOGENIC DRUGS | ABBOTT LABORATORIES (US) | 2001-02-28 | — | — | EP | claimed |
| EP-0976735-A1 | PROCESS FOR PRODUCING PIPERIDINECARBOXYLIC ACID AMIDES | Ajinomoto Co., Inc. (JP) | 2000-02-02 | — | — | EP | claimed |
| WO-1999061476-A1 | PEPTIDE ANTIANGIOGENIC DRUGS | ABBOTT LABORATORIES (US) | 1999-12-02 | — | — | WO | claimed |
| CN-1112560-A | Piperidine derivatives and anti-platelet agents containing the same | AJINOMOTO KK (JP) | 1995-11-29 | — | — | CN | claimed |
| EP-0682015-A1 | Piperidine derivates and anti-platelet agents containing the same | Ajinomoto Co., Inc. (JP) | 1995-11-15 | — | — | EP | claimed |
| US-4623715-A | ANTIDEPRESSANTS | HOECHST AKTIENGESELLESCHAFT (DE) | 1986-11-18 | — | — | US | claimed |